• Home
  • About us
Redefining Healthy Longevity
Through Precision Immune Resilience

Overview

Company

Redefining Recovery Beyond Treatment

History

Our Journey Toward a Healthier Future

  • 2021
    Apr.
    IMMUNIQUE Inc. established
    Nov.
    Certified as a Venture Enterprise
  • 2022
    Feb.
    Established the R&D Center for Cellular Immunotherapy
    Apr.
    Certified as a Corporate-Affiliated Research Institute
    Nov.
    Patent application filed: Enhanced regulatory T cells and method of manufacturing
    thereof
  • 2023
    Mar.
    Signed an MOU for joint R&D with the Hanyang University Institute for
    Rheumatology Research
    Apr.
    Selected for a national R&D project under the Korean Fund for Regenerative
    Medicine
    Nov.
    Signed an MOU for joint R&D with Kine Sciences
  • 2024
    Jun.
    Winner of the 2024 Korea Leading Company Award — Bio Category
    Sep.
    Appointment of SO MEE KWON as CEO
  • 2025
    Jun.
    Selected as a corporate partner in Ajou University Hospital’s Korea Research-Driven
    Hospitals
    Sep.
    Signed an MOU for joint R&D with Ewha Womans University Mokdong Hospital
    Dec.
    Signed an MOU for educational cooperation with CHA University Graduate School
    of Clinical Pharmacy
Address

Address

Directions

  • 21, Daewangpangyo-ro 644-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 13494, Korea
  • 031-620-4200
  • 031-620-4299